Vaxfab Enterprises Ltd

Vaxfab Enterprises Board Meeting Date

Vaxfab Enterprises Ltd has scheduled a board meeting for October 01, 2026, to consider a proposal for raising funds through the issuance of securities.

Vaxfab Enterprises Annual General Meeting

Vaxfab Enterprises Limited has scheduled its 43rd Annual General Meeting for September 29, 2026. The meeting will address financial adoption, director reappointment, and authorized capital increase.

Vaxfab Enterprises Capital Structure Change

Vaxfab Enterprises Ltd approved an increase in its authorized share capital from 3.5 Crore to 5 Crore equity/preference shares. The proposal awaits shareholder approval.

Vaxfab Enterprises Board Meeting Outcome

Vaxfab Enterprises' board approved increasing authorized capital from ₹35 Cr to ₹50 Cr and set the 43rd AGM for 29 September 2026.

Vaxfab Enterprises Capital Structure Change

Vaxfab Enterprises Limited allotted 8,26,761 equity shares upon conversion of warrants on a preferential basis. This issuance increases the company's paid-up equity share capital.

Vaxfab Enterprises Q1 FY27 Results: Net Loss of ₹5.8 Cr

Vaxfab Enterprises Ltd reported revenue from operations of ₹0.4 Cr (-97.3% YoY) and a net loss of ₹5.8 Cr for Q1 FY27.

Key figure

Net loss ₹5.8 Cr

Vaxfab Enterprises Merger & Restructuring

Vaxfab Enterprises has incorporated a new wholly owned subsidiary, Al Rafa Enterprise FZ-LLC, in the United Arab Emirates. The entity is yet to commence business operations.

Vaxfab Enterprises Board Meeting Date

Vaxfab Enterprises has scheduled a board meeting for August 14, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.

Vaxfab Enterprises Other Announcement

Vaxfab Enterprises disclosed shareholding patterns for the quarter ending June 30, 2026. This follows multiple preferential allotments of warrants and equity shares approved between January and May 2026.

Vaxfab Enterprises Board Meeting Outcome

Vaxfab Enterprises Ltd reports the Board's approval of audited standalone and consolidated financial results for FY 2025‑26. The outcome is filed as a revised board meeting notice.

Vaxfab Enterprises Q4 FY26 Results: Net Profit ₹2.1 Cr, Up 162.5% YoY

Vaxfab Enterprises Ltd reported revenue from operations of ₹46 Cr (+90.1% YoY) and net profit of ₹2.1 Cr (+162.5% YoY) for Q4 FY26.

Key figure

Net profit ₹2.1 Cr · +162.5% YoY

Vaxfab Enterprises Q4 FY26 Results: Net Profit ₹3 Cr, Up 328.6% YoY

Vaxfab Enterprises Ltd reported revenue from operations of ₹8.8 Cr (-85.0% YoY) and net profit of ₹3 Cr (+328.6% YoY) for Q4 FY26.

Key figure

Net profit ₹3 Cr · +328.6% YoY

Vaxfab Enterprises Financial Results

Vaxfab Enterprises approved its audited FY26 financial results, reporting standalone total revenue of ₹99.60 Crore. The statutory auditor issued a disclaimer of opinion regarding record maintenance.

Vaxfab Enterprises Other Announcement

Vaxfab Enterprises Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with SEBI norms.

Vaxfab Enterprises Board Meeting Date

Vaxfab Enterprises scheduled a Board Meeting on May 30, 2026, to approve audited financial results. The trading window remains closed for designated persons until June 1.

Vaxfab Enterprises Results Correction

Vaxfab Enterprises corrected a clerical error regarding the allotment of 14,81,068 equity shares. This issuance, valued at ₹3.11 Crore, follows a warrant conversion exercise.

Value

₹3.11 Cr

Vaxfab Enterprises Capital Structure Change

Vaxfab Enterprises allotted 19,50,348 equity shares following warrant conversions at Rs. 21.02 each. This ₹4.1 Crore issuance increases the total paid-up capital to ₹25.47 Crore.

Value

₹4.10 Cr

Execution

18 months

Vaxfab Enterprises Capital Structure Change

Vaxfab Enterprises Limited allotted 13,18,550 equity shares at ₹21.02 each following the conversion of warrants. This transaction, valued at approximately ₹2.77 Crore, increased the company's paid-up equity share capital to ₹23.52 Crore.

Value

₹2.77 Cr

Vaxfab Enterprises Capital Structure Change

Vaxfab Enterprises Ltd clarified a typographical error regarding its March 17, 2026, warrant conversion outcome. The corrected allotment is 27,33,902 equity shares at Rs. 21.02 each, totaling approximately ₹5.75 Crore. All other terms and conditions of the allotment remain unchanged.

Value

₹5.75 Cr

Vaxfab Enterprises Financial Results

Vaxfab Enterprises Ltd reported its unaudited financial results for the quarter ended December 31, 2025. Consolidated total income stood at ₹12.29 Crore, with a net loss of ₹3.24 Crore. The statutory auditors issued a disclaimer of opinion due to missing historical records and lack of documentation regarding loans and asset impairments.